NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/04/2026
Voltar para busca
Dado oficial do USPTO
RHINOZYN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
24/04/2026
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
03/06/2019
Data de registro
17/11/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/11/2020
Última transação
24/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH
Examinador
EISNACH, MICHAEL PATRICK
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Bluestone Pharma GmbH
Representantes
Devasena Reddy
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Probiotic bacterial formulations being other than for medical use not to be administered or ingested nasallyprobiotic bacteria and probiotic bacterial cultures for use as ingredient for food and beverages; chemicals used in industry not to be administered or ingested nasally; chemical substances for preserving foodstuffs not to be administered or ingested nasally
Classe 5
Probiotic bacterial formulations for medical use not to be administered or ingested nasally; dietary supplements and dietetic preparations in the nature of dietetic foods adapted for medical use not to be administered or ingested nasally; chewing gum for medical purposes; pharmaceutical preparations not to be administered or ingested nasallypharmaceutical preparations for the treatment of allergic rhinitis; dietetic foods for medicinal purposes; dietetic products for medical purposesdietetic preparations in the nature of food adapted for medical use; dietetic substances in the nature of food adapted for medical use; dietary supplements; bacterial preparations for medical use not to be administered or ingested nasally
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/11/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/02/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/02/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/02/2021
FIMP
FINAL DISPOSITION PROCESSED
25/02/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/02/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/02/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
17/11/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
11/10/2020
APET
ASSIGNED TO PETITION STAFF
08/10/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
27/08/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
21/08/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
13/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/02/2020
PUBO
PUBLISHED FOR OPPOSITION
18/02/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/01/2020
ALIE
ASSIGNED TO LIE
14/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2020
RFNT
REFUSAL PROCESSED BY IB
12/10/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/09/2019
RFRR
REFUSAL PROCESSED BY MPU
26/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
17/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
DOCK
ASSIGNED TO EXAMINER
11/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RHINOZYN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.